Correction: Wind et al. Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial. Cancers 2022, 14, 1510

Detalles Bibliográficos
Autores principales: Wind, Selinde S., Jansen, Manon A. A., Rijsbergen, Melanie, van Esdonk, Michiel J., Ziagkos, Dimitrios, Cheng, Wing C., Niemeyer-van der Kolk, Tessa, Korsten, John, Gruszka, Agnieszka, Schmitz-Rohmer, Debora, Bonnel, David, Legouffe, Raphael, Barré, Florian, Bekkenk, Marcel W., de Haas, Ellen R. M., Quint, Koen D., Schnidar, Harald, Rolli, Melanie, Streefkerk, Henk Johan, Burggraaf, Jacobus, Vermeer, Maarten H., Rissmann, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001047/
https://www.ncbi.nlm.nih.gov/pubmed/36900424
http://dx.doi.org/10.3390/cancers15051485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001047/
https://www.ncbi.nlm.nih.gov/pubmed/36900424
http://dx.doi.org/10.3390/cancers15051485

Ejemplares similares